Подписаться
Mitch A. Phelps
Mitch A. Phelps
Подтвержден адрес электронной почты в домене osu.edu
Название
Процитировано
Процитировано
Год
Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia
JC Byrd, TS Lin, JT Dalton, D Wu, MA Phelps, B Fischer, M Moran, ...
Blood 109 (2), 399-404, 2007
4622007
Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells
X Zhu, M Badawi, S Pomeroy, DS Sutaria, Z Xie, A Baek, J Jiang, ...
Journal of extracellular vesicles 6 (1), 1324730, 2017
4152017
Multi-institutional phase II study of selumetinib in patients with metastatic biliary cancers
T Bekaii-Saab, MA Phelps, X Li, M Saji, L Goff, JSW Kauh, BH O'Neil, ...
Journal of clinical oncology 29 (17), 2357, 2011
3502011
Discovery and mechanism of highly efficient cyclic cell-penetrating peptides
Z Qian, A Martyna, RL Hard, J Wang, G Appiah-Kubi, C Coss, MA Phelps, ...
Biochemistry 55 (18), 2601-2612, 2016
2892016
miR-221 silencing blocks hepatocellular carcinoma and promotes survival
JK Park, T Kogure, GJ Nuovo, J Jiang, L He, JH Kim, MA Phelps, ...
Cancer research 71 (24), 7608-7616, 2011
2892011
Phase II study of flavopiridol in relapsed chronic lymphocytic leukemia demonstrating high response rates in genetically high-risk disease
TS Lin, AS Ruppert, AJ Johnson, B Fischer, NA Heerema, LA Andritsos, ...
Journal of Clinical Oncology 27 (35), 6012, 2009
2892009
Favorable effects of weak acids on negative-ion electrospray ionization mass spectrometry
Z Wu, W Gao, MA Phelps, D Wu, DD Miller, JT Dalton
Analytical chemistry 76 (3), 839-847, 2004
2512004
Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats
W Gao, PJ Reiser, CC Coss, MA Phelps, JD Kearbey, DD Miller, ...
Endocrinology 146 (11), 4887-4897, 2005
2302005
Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia
MA Phelps, TS Lin, AJ Johnson, E Hurh, DM Rozewski, KL Farley, D Wu, ...
Blood, The Journal of the American Society of Hematology 113 (12), 2637-2645, 2009
2062009
Pharmacogenomic testing: relevance in medical practice: why drugs work in some patients but not in others
JP Kitzmiller, DK Groen, MA Phelps, W Sadee
Cleveland Clinic journal of medicine 78 (4), 243, 2011
1802011
The extracellular RNA communication consortium: establishing foundational knowledge and technologies for extracellular RNA research
S Das, AB Abdel-Mageed, C Adamidi, PD Adelson, KM Akat, E Alsop, ...
Cell 177 (2), 231-242, 2019
1722019
REO-10: a phase I study of intravenous reovirus and docetaxel in patients with advanced cancer
C Comins, J Spicer, A Protheroe, V Roulstone, K Twigger, CM White, ...
Clinical cancer research 16 (22), 5564-5572, 2010
1522010
Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: a randomized phase 1 study
R Molokie, D Lavelle, M Gowhari, M Pacini, L Krauz, J Hassan, V Ibanez, ...
PLoS medicine 14 (9), e1002382, 2017
1322017
Discovery of anticancer agents of diverse natural origin
AD Kinghorn, EJC De Blanco, DM Lucas, HL Rakotondraibe, J Orjala, ...
Anticancer research 36 (11), 5623-5637, 2016
1192016
Dose escalation of lenalidomide in relapsed or refractory acute leukemias
W Blum, RB Klisovic, H Becker, X Yang, DM Rozewski, MA Phelps, ...
Journal of clinical oncology 28 (33), 4919, 2010
1162010
Achieving the promise of therapeutic extracellular vesicles: the devil is in details of therapeutic loading
DS Sutaria, M Badawi, MA Phelps, TD Schmittgen
Pharmaceutical research 34, 1053-1066, 2017
1152017
Structurally modified curcumin analogs inhibit STAT3 phosphorylation and promote apoptosis of human renal cell carcinoma and melanoma cell lines
MA Bill, C Nicholas, TA Mace, JP Etter, C Li, EB Schwartz, JR Fuchs, ...
Public Library of Science 7 (8), e40724, 2012
992012
Modeling of active transport systems
EY Zhang, MA Phelps, C Cheng, S Ekins, PW Swaan
Advanced Drug Delivery Reviews 54 (3), 329-354, 2002
992002
PRMT5 as a druggable target for glioblastoma therapy
YK Banasavadi-Siddegowda, AM Welker, M An, X Yang, W Zhou, G Shi, ...
Neuro-oncology 20 (6), 753-763, 2018
922018
Resistance to the Translation Initiation Inhibitor Silvestrol is Mediated by ABCB1/P-Glycoprotein Overexpression in Acute Lymphoblastic Leukemia Cells
SV Gupta, EJ Sass, ME Davis, RB Edwards, G Lozanski, NA Heerema, ...
The AAPS journal 13, 357-364, 2011
862011
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20